C Benjwal - Bharat Immunologicals Insider

VP of FandA and Member of Share Transfer and Shareholders'/Investors' Grievance Committee

We currently do not have informatin regarding C Benjwal. This executive tanure with Bharat Immunologicals Biologicals Corp Ltd is not currenlty determined.
91 57 3223 8758  http://www.bibcol.com

Management Efficiency

The company has return on total asset (ROA) of (1.69) % which means that it has lost $1.69 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (11.52) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 177.56 M in total debt with debt to equity ratio (D/E) of 0.5 which is about average as compared to similar companies. Bharat Immunologicals Biologicals Corp Ltd has Current Ratio of 1.66 which is within standard range for the sector.

Similar Executives

Found 1 records

VP Since

Mehul ShahCadila Healthcare Limited

Entity Summary

Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals solutions in India. Bharat Immunologicals Biologicals Corp Ltd (BIBCL) is traded on Bombay Stock Exchange in India. It is located in Bulandshahr, and employs 5 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Bharat Immunologicals Biologicals Corp Ltd to your portfolio

Top Management

Bharat Immunologicals Leadership Team
U Singh, CFO
C Benjwal, VP
Sunil Sharma, Executive
Mrs Bhatia, Managing Director
Sandip Lal, Executive
Sreeshan Raghavan, Chairman
Indrajit Singh, Executive
M Bhatia, Managing Director

Stock Performance

Bharat Immunologicals Performance Indicators